12 November - 13 November 2018
2nd SCI/RSC Symposium on Antimicrobial Drug Discovery
Organised by:
SCI's Fine Chemicals Group and RSC's Biological and Medicinal Chemistry Sector
London, UK
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
Rising antimicrobial resistance is decreasing the efficacy of existing treatments for infection. With the alarming prospect of a post-antibiotic era, it is vital that we refresh the drug pipeline with new therapies and therapeutics that act through novel modes of action. With pressure from governments and increased public awareness of this growing problem, renewed interest from industry and academia has led to a resurgence in antimicrobial drug discovery, with the exciting prospect of new and innovative technologies and approaches for combating infection.
Following the first successful event in 2016, this meeting will examine the current state of the art in antimicrobial drug discovery from a medicinal chemist's perspective. Coinciding with World Antibiotics Awareness week, a two-day programme of speakers from industry and academia wil highlight the challenges associated with discovering and developing new antimicrobials, whilst also showcasing emerging strategies that are being developed to tackle infection.
Attendees
Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery. With great opportunities for academic-industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.Programme
| 12:00 | Registration, exhibition and lunch | |
| 13:00 | Opening remarks | |
| 13:10 | Antibiotics: challenges and opportunities Dr Stephen Baker, GlaxoSmithKline |
|
| 13:55 | Rational and irrational discovery of novel interventions to treat drug-resistant infections Prof Matt Cooper, University of Queensland and Inflazome |
|
| 14:40 | Flash poster presentations | |
| 15:00 | Refreshment break and exhibition | |
| 15:30 | Towards photopharmacological antimicrobial chemotherapy Dr Matthew Fuchter, Imperial College London |
|
| 16.00 | SPARKing new antibiotic discovery Wes Kim, The Pew Charitable Trusts |
|
| 16:30 | Research and development of new antimicrobial drugs and combinations: a not-for-profit approach Prof Laura Piddock, Global Antibiotic Research & Development Partnership (GARDP) |
|
| 17:15 | Networking and refreshments | |
Tuesday 13 November
| 09:00 | Rules for bacterial penetration - what we know and what we don't Dr Paul Finn, Oxford Drug Design |
|
| 09:30 | Reversing efflux-mediated resistance to reinvent broad-spectrum antibiotics Dr K Miraz Rahman, King's College London |
|
| 10:00 | Predictive guidelines for compound accumulation lead to new broad-spectrum antibiotics Prof Paul Hergenrother, University of Illinois |
|
| 10:45 | Refreshment break and exhibition | |
| 11:15 | Non-hydroxamate LpxC inhibitors Dr Alastair Parkes, Evotec |
|
| 11:45 | Novel immunotherapeutics to target Gram-negative bacterial infections Dr Emma Leire, Centauri Therapeutics |
|
| 12:15 | Analysis of potassium (K+) efflux systems (Kef) as an antibiotic target in pathogenic bacteria Catherine Haslam, University of Oxford |
|
| 12:30 | Turning strength into a weakness: exploiting resistance as a novel therapeutic target Lindsay Evans, Imperial College London |
|
| 12:45 | MAPS: Multiparameter Assay for Profiling Susceptibility Dr Lisa Miller, University of York |
|
| 13:00 | Lunch and exhibition | |
| 14:00 | Short antimicrobial peptides - their potential against multidrug resistant bacteria Dr Kai Hilpert, St George's, University of London |
|
| 14:30 | From HTS to preclinical candidate: a novel small-molecule antibiotic for the treatment of drug-resistant Neisseria gonorrhoeae Dr Paul Meo, Summit Therapeutics |
|
| 15:00 | Refreshment break and exhibition | |
| 15:30 | Metallo β-lactamase inhibitors: an approach to combat the threat of emerging carbapenem resistance due to metallo β-lactamase enzymes in Gram-negative bacteria Dr David Davies, AntaBio |
|
| 16:00 | Challenges in antibacterial drug discovery Prof Ian Gilbert, University of Dundee |
|
| 16:45 | Closing remarks |
Venue and Contact
SCI
14/15 Belgrave Square
London
SW1X 8PS
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org
Fees
Early bird fees before Friday 5 October 2018
| £150 | SCI / RSC Member | |
| £50 | SCI / RSC Student Member | |
| £100 | SCI / RSC Subsidised Member | |
| £180 | One Nucleus Member | |
| £200 | Non-Member |
Standard fees after Friday 5 October 2018
| £180 | SCI / RSC Member | |
| £60 | SCI / RSC Student Member | |
| £120 | SCI / RSC Subsidised Member | |
| £220 | One Nucleus Member | |
| £240 | Non-Member |
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
For booking terms and conditions click here.CPD Info
SCI Members attending this meeting are able to claim CPD points.
Partners
Exhibitors
Sponsors
Additional Info
Call for Abstracts for Short Talks from Early Career Researchers
Early career researchers wishing to give a short talk (10 minutes) are encouraged to submit a one-page abstract to conferences@soci.org by Friday 15 June 2018 with "AMR short talk abstract" in the subject line. Unsuccessful applicants will automatically be considered to present a poster.
Call for Poster Abstracts
Anyone wishing to present a poster should submit a one-page abstract to conferences@soci.org by Friday 14 September 2018 with "AMR - poster abstract" in the subject line. Selected poster presenters will be given the opportunity to give a flash presentation.
Bursaries
A limited number of bursaries are available to SCI/RSC student members to cover their registration fees and contribute to their travel and accommodation costs. To apply for a bursary, please send an email to conferences@soci.org by Friday 14 September 2018 with "AMR II - bursary application" in the subject line.
Exhibition and Sponsorship
An exhibition will take place alongside the conference. Companies and related organisations who may wish to exhibit, please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.
Organising Committee
- Dr Liam Cox, SCI / University of Birmingham
- Dr Caroline Low, SCI / Computational Medicinal Chemistry Consultant
- Dr Sarah Major, SCI / Evotec (UK) Ltd
- Dr Pascal Savy, SCI / Charles River Laboratories
- Dr Francis Wilson, RSC / Summit Therapeutics
